Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
BioNTech
BNTX
$23.1B
| $42.9M | 0.01% |
287,885
+116,888
| +68% | +$17.9M |
|
1102
Arthur J. Gallagher & Co
AJG
$65.5B
| $42.9M | 0.01% |
263,234
-563,797
| -68% | -$93.6M |
|
1103
PUT
Lyft
LYFT
$6.48B
| $42.9M | 0.01% |
3,231,300
+728,300
| +29% | +$17M |
|
1104
PUT
Energy Transfer Partners
ET
$71.5B
| $42.9M | 0.01% |
4,299,200
+674,988
| +19% | +$7.56M |
|
1105
PUT
Cameco
CCJ
$42.6B
| $42.8M | 0.01% |
2,035,300
+293,300
| +17% | +$7.4M |
|
1106
Microchip Technology
MCHP
$42.2B
| $42.6M | 0.01% |
733,947
+186,081
| +34% | +$12.3M |
|
1107
CALL
Beyond Meat
BYND
$214M
| $42.5M | 0.01% |
59,223
+10,316
| +21% | +$9.89M |
|
1108
Keysight
KEYS
$60.6B
| $42.5M | 0.01% |
308,533
-205,212
| -40% | -$29.2M |
|
1109
Biogen
BIIB
$30.9B
| $42.5M | 0.01% |
208,443
+130,048
| +166% | +$26.6M |
|
1110
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.23B
| $42.5M | 0.01% |
602,656
+592,433
| +5,795% | +$45M |
|
1111
CALL
iShares MSCI Japan ETF
EWJ
$23.2B
| $42.4M | 0.01% |
803,500
+449,700
| +127% | +$25.4M |
|
1112
iShares MSCI United Kingdom ETF
EWU
$4.13B
| $42.3M | 0.01% |
1,412,234
+1,387,739
| +5,665% | +$44.6M |
|
1113
PUT
ProShares Bitcoin Strategy ETF
BITO
$1.43B
| $42.3M | 0.01% |
3,640,400
+1,246,800
| +52% | +$25.1M |
|
|
BLU
1114
DELISTED
BELLUS Health Inc.
BLU
| $42.2M | 0.01% |
4,571,004
-329,376
| -7% | -$2.69M |
|
1115
PUT
HP
HPQ
$28.6B
| $42.2M | 0.01% |
1,286,700
+340,100
| +36% | +$12.5M |
|
1116
State Street Materials Select Sector SPDR ETF
XLB
$8.57B
| $42M | 0.01% |
1,142,574
+688,734
| +152% | +$28.8M |
|
1117
PUT
CarMax
KMX
$8.52B
| $41.9M | 0.01% |
462,600
+210,500
| +83% | +$19.8M |
|
1118
Texas Capital Bancshares
TCBI
$4.38B
| $41.7M | 0.01% |
792,687
+709,324
| +851% | +$38M |
|
1119
Constellation Energy
CEG
$98.7B
| $41.7M | 0.01% |
728,476
-593,654
| -45% | -$35.7M |
|
1120
CALL
Kroger
KR
$35.1B
| $41.7M | 0.01% |
880,100
-104,700
| -11% | -$5.58M |
|
1121
CALL
Darden Restaurants
DRI
$25.9B
| $41.6M | 0.01% |
367,900
+1,900
| +0.5% | +$237K |
|
1122
Haemonetics
HAE
$4.11B
| $41.6M | 0.01% |
+638,444
| New | +$37.8M |
|
1123
Healthpeak Properties
DOC
$14.3B
| $41.6M | 0.01% |
1,603,896
+340,446
| +27% | +$10.3M |
|
1124
Shift4
FOUR
$3.79B
| $41.5M | 0.01% |
1,254,255
+1,019,171
| +434% | +$48.1M |
|
1125
Aflac
AFL
$60.5B
| $41.3M | 0.01% |
747,262
+330,338
| +79% | +$19.5M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.